These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 15885086)

  • 1. Nature, nurture and neurology: gene-environment interactions in neurodegenerative disease. FEBS Anniversary Prize Lecture delivered on 27 June 2004 at the 29th FEBS Congress in Warsaw.
    Spires TL; Hannan AJ
    FEBS J; 2005 May; 272(10):2347-61. PubMed ID: 15885086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mediators, environmental modulators and experience-dependent synaptic dysfunction in Huntington's disease.
    Hannan AJ
    Acta Biochim Pol; 2004; 51(2):415-30. PubMed ID: 15218539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enriched environments, experience-dependent plasticity and disorders of the nervous system.
    Nithianantharajah J; Hannan AJ
    Nat Rev Neurosci; 2006 Sep; 7(9):697-709. PubMed ID: 16924259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental enrichment and neurodegenerative diseases.
    Li L; Tang BL
    Biochem Biophys Res Commun; 2005 Aug; 334(2):293-7. PubMed ID: 15961061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What transgenic mice tell us about neurodegenerative disease.
    Gurney ME
    Bioessays; 2000 Mar; 22(3):297-304. PubMed ID: 10684590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genes and the environment in neurodegeneration.
    Coppedè F; Mancuso M; Siciliano G; Migliore L; Murri L
    Biosci Rep; 2006 Oct; 26(5):341-67. PubMed ID: 17029001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural phenotyping of transgenic mice.
    Brown RE
    Can J Exp Psychol; 2007 Dec; 61(4):328-44. PubMed ID: 18266509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse models of neurodegenerative diseases: criteria and general methodology.
    Janus C; Welzl H
    Methods Mol Biol; 2010; 602():323-45. PubMed ID: 20012407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene-environment interactions, neuronal dysfunction and pathological plasticity in Huntington's disease.
    van Dellen A; Grote HE; Hannan AJ
    Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1007-19. PubMed ID: 16445565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic mouse models of neurodegenerative diseases.
    Trancikova A; Ramonet D; Moore DJ
    Prog Mol Biol Transl Sci; 2011; 100():419-82. PubMed ID: 21377633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drosophila models of human neurodegenerative disease.
    Chan HY; Bonini NM
    Cell Death Differ; 2000 Nov; 7(11):1075-80. PubMed ID: 11139281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington's disease transgenic mice.
    Nithianantharajah J; Barkus C; Murphy M; Hannan AJ
    Neurobiol Dis; 2008 Mar; 29(3):490-504. PubMed ID: 18165017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environmental factors as modulators of neurodegeneration: insights from gene-environment interactions in Huntington's disease.
    Mo C; Hannan AJ; Renoir T
    Neurosci Biobehav Rev; 2015 May; 52():178-92. PubMed ID: 25770041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling brain reserve: experience-dependent neuronal plasticity in healthy and Huntington's disease transgenic mice.
    Nithianantharajah J; Barkus C; Vijiaratnam N; Clement O; Hannan AJ
    Am J Geriatr Psychiatry; 2009 Mar; 17(3):196-209. PubMed ID: 19454847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic animal models of neurodegenerative diseases and their application to treatment development.
    Rockenstein E; Crews L; Masliah E
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1093-102. PubMed ID: 17869376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental enrichment enhances cellular plasticity in transgenic mice with Alzheimer-like pathology.
    Herring A; Ambrée O; Tomm M; Habermann H; Sachser N; Paulus W; Keyvani K
    Exp Neurol; 2009 Mar; 216(1):184-92. PubMed ID: 19118549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global changes to the ubiquitin system in Huntington's disease.
    Bennett EJ; Shaler TA; Woodman B; Ryu KY; Zaitseva TS; Becker CH; Bates GP; Schulman H; Kopito RR
    Nature; 2007 Aug; 448(7154):704-8. PubMed ID: 17687326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proteins and mutations: a new vision (molecular) of neurodegenerative diseases].
    Christen Y
    J Soc Biol; 2002; 196(1):85-94. PubMed ID: 12134639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior.
    Mattson MP; Chan SL; Duan W
    Physiol Rev; 2002 Jul; 82(3):637-72. PubMed ID: 12087131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.